do-me/EUR-LEX huggingface dataset:
Political and Security Committee Decision (CFSP) 2022/512 of 23 March 2022 on the reconfirmation of the authorisation of the European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) (EUNAVFOR MED IRINI/1/2022)
Date: 2022-03-23
Institutions: Political and Security Committee
Subjects: EU military mission, EU restrictive measure, Libya, Mediterranean region (EU), arms trade, firearms and munitions, illicit trade, military cooperation








L_2022103EN.01001101.xml










31.3.2022   


EN


Official Journal of the European Union


L 103/11








            POLITICAL AND SECURITY COMMITTEE DECISION (CFSP) 2022/512
of 23 March 2022
         
on the reconfirmation of the authorisation of the European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) (EUNAVFOR MED IRINI/1/2022)


THE POLITICAL AND SECURITY COMMITTEE,

Having regard to the Treaty on European Union, and in particular Article 38 thereof,


Having regard to Council Decision (CFSP) 2020/472 of 31 March 2020 on a European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) (1), and in particular Article 8(3) thereof,

Whereas:







(1)


On 31 March 2020, the Council adopted Decision (CFSP) 2020/472, which established and launched a European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) for the period until 31 March 2021.












(2)


Article 8(3) of Decision (CFSP) 2020/472 provides that, notwithstanding that period, the authorisation of the operation is to be reconfirmed every 4 months and that the Political and Security Committee is to prolong the operation unless the deployment of maritime assets of the operation produces a pull effect on migration on the basis of substantiated evidence gathered according to the criteria set out in the Operations Plan.












(3)


On 26 March 2021, the Council adopted Decision (CFSP) 2021/542 (2), extending the operation until 31 March 2023, subject to the same reconfirmation procedure.












(4)


The Operation Commander provided monthly pull factor reports.












(5)


The authorisation of the operation should be reconfirmed for the seventh four-month sub-period of its mandate and the operation should be prolonged accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The authorisation of EUNAVFOR MED IRINI is hereby reconfirmed and the operation is prolonged from 1 April 2022 to 31 July 2022.


Article 2
This Decision shall enter into force on the date of its adoption.




Done at Brussels, 23 March 2022.


For the Political and Security Committee


The Chairperson

D. PRONK
            





(1)  
            OJ L 101, 1.4.2020, p. 4.

(2)  Council Decision (CFSP) 2021/542 of 26 March 2021 amending Decision (CFSP) 2020/472 on the European Union military operation in the Mediterranean (EUNAVFOR MED IRINI) (OJ L 108, 29.3.2021, p. 57).
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 130/07
Date: 2022-03-23
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical compound, chemical product, health control, health risk, market approval, marketing standard, pharmaceutical industry, polishing and scouring preparations, solvent








C_2022130EN.01000901.xml










23.3.2022   


EN


Official Journal of the European Union


C 130/9






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 130/07)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 1506


16 March 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


Octapharma AB, Lars Forssells gata 23, SE-11275 Stockholm, Sweden
Octapharma
Produktionsgesel schaft Deutschland mbH, Wolfgang- Marguerre-Allee 1, 31832 Springe, Germany
Octapharma S.A.S. 72 rue du Maréchal Foch, 67381 Lingolsheim, France


REACH/22/5/0
REACH/22/5/1
REACH/22/5/2
REACH/22/5/3


As detergent for a virus inactivation step (solvent/detergent treatment) during the manufacture of plasma-derived and recombinant medicinal products


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.




Octapharma Pharmazeutika Produktionsgesellschaft m.b.H, Oberlaaer Straße 235, A-1100 Vienna, Austria


REACH/22/5/4


As component of a chromatography column regeneration solution during the manufacture of a recombinant-derived Factor VIII


4 January 2025






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Non-opposition to a notified concentration (Case M.10611 – GENERALI FRANCE / LA MÉDICALE) (Text with EEA relevance) 2022/C 147/01
Date: 2022-03-23
Institutions: Directorate-General for Competition, European Commission
Subjects: economic concentration, financial services, health care profession, indemnity insurance, life assurance, merger control








C_2022147EN.01000101.xml










4.4.2022   


EN


Official Journal of the European Union


C 147/1






Non-opposition to a notified concentration
(Case M.10611 – GENERALI FRANCE / LA MÉDICALE)
(Text with EEA relevance)
(2022/C 147/01)
On 23 March 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10611. EUR-Lex is the online point of access to European Union law.






(1)  OJ L 24, 29.1.2004, p. 1.
Opinion of the European Economic and Social Committee on the Proposal for a Regulation of the European Parliament and of the Council laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised in accordance with Directive 2001/82/EC and Regulation (EC) No 726/2004 (COM(2022) 76 final — 2022/0053 (COD))
Date: 2022-03-23
Institutions: European Economic and Social Committee
Subjects: consumer information, labelling, market approval, marketing standard, packaging, pharmaceutical legislation, product designation, veterinary medicinal product








C_2022290EN.01015301.xml










29.7.2022   


EN


Official Journal of the European Union


C 290/153






Opinion of the European Economic and Social Committee on the Proposal for a Regulation of the European Parliament and of the Council laying down transitional rules for the packaging and labelling of veterinary medicinal products authorised in accordance with Directive 2001/82/EC and Regulation (EC) No 726/2004
(COM(2022) 76 final — 2022/0053 (COD))
(2022/C 290/27)






Referral


European Parliament, 7.3.2022
Council, 11.3.2022




Legal basis


Articles 114 and 168(4)(b) and article 304 of the Treaty on the Functioning of the European Union




Section responsible


Agriculture, Rural Development and the Environment




Adopted at plenary


23.3.2022




Plenary session No


568




Outcome of vote
(for/against/abstentions)


193/0/4




Since the Committee endorses the content of the proposal and feels that it requires no comment on its part, it decided, at its 568th plenary session of 23 and 24 March 2022 (meeting of 23 March), by 193 votes in favour with 4 abstentions, to issue an opinion endorsing the proposed text.

Brussels, 23 March 2022.


The President of the European Economic and Social Committee

Christa SCHWENG
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2022/C 130/12
Date: 2022-03-23
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, coal, health control, health risk, market approval, marketing standard, petroleum product








C_2022130EN.01001401.xml










23.3.2022   


EN


Official Journal of the European Union


C 130/14






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))

(Text with EEA relevance)
(2022/C 130/12)

Decision partially granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 1500


16 March 2022


Pitch, coal tar, high-temp. (‘CTPht’)
EC No: 266-028-2, CAS No: 65996-93-2


Bilbaina de Alquitranes, S.A., Obispo Olaechea 49, 48903, Luchana-Baracaldo, Vizcaya, Spain


REACH/22/12/0


Use of CTPht in formulation of mixtures exclusively for industrial uses that are outside the scope of the authorisation requirement set out in Regulation (EC) No 1907/2006


4 October 2032


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.




Anthracene oil (‘AO’)
EC No: 292-602-7, CAS No: 90640-80-5


REACH/22/12/1


Use of AO in formulation of mixtures exclusively for industrial uses that are outside the scope of the authorisation requirement set out in Regulation (EC) No 1907/2006






(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Opinion of the European Economic and Social Committee on the Proposal for a Council Directive amending Directive 2006/112/EC as regards the extension of the application period of the optional reverse charge mechanism in relation to supplies of certain goods and services susceptible to fraud and of the Quick Reaction Mechanism against VAT fraud (COM(2022) 39 final — 2022/0027 (CNS))
Date: 2022-03-23
Institutions: European Economic and Social Committee
Subjects: VAT, basis of tax assessment, goods and services, provision of services, supply, tax harmonisation, tax law, tax offence, taxpayer








C_2022290EN.01015101.xml










29.7.2022   


EN


Official Journal of the European Union


C 290/151






Opinion of the European Economic and Social Committee on the Proposal for a Council Directive amending Directive 2006/112/EC as regards the extension of the application period of the optional reverse charge mechanism in relation to supplies of certain goods and services susceptible to fraud and of the Quick Reaction Mechanism against VAT fraud
(COM(2022) 39 final — 2022/0027 (CNS))
(2022/C 290/25)






Referral


Council of the European Union, 28.2.2022




Legal basis


Article 113 of the Treaty on the Functioning of the European Union




Section responsible


Economic and Monetary Union and Economic and Social Cohesion




Adopted at plenary


23.3.2022




Plenary session No


568




Outcome of vote
(for/against/abstentions)


194/1/4




Since the Committee endorses the content of the proposal for a Council Directive amending Directive 2006/112/EC as regards the extension of the application period of the optional reverse charge mechanism in relation to supplies of certain goods and services susceptible to fraud and of the Quick Reaction Mechanism against VAT fraud and feels that it requires no comment on its part, it decided, at its 568th plenary session of 23 and 24 March 2022, (meeting of 23 March), by 196 votes to 1 with 4 abstentions, to issue an opinion endorsing the proposed text.

Brussels, 23 March 2022.


The President of the European Economic and Social Committee

Christa SCHWENG
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006 , p. 1.)) (Text with EEA relevance) 2022/C 130/04
Date: 2022-03-23
Institutions: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission
Subjects: chemical product, coronavirus disease, health control, health risk, market approval, marketing standard, medical device, medical diagnosis








C_2022130EN.01000501.xml










23.3.2022   


EN


Official Journal of the European Union


C 130/5






Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)


(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1)
)


(Text with EEA relevance)
(2022/C 130/04)

Decision granting an authorisation













Reference of the decision (2)



Date of decision


Substance name


Holder of the authorisation


Authorisation number


Authorised use


Date of expiry of review period


Reasons for the decision




C(2022) 1498


16 March 2022


4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated
(4-tert-OPnEO)
EC No: -, CAS No:-


SEBIA, Parc Technologique Léonard de Vinci, 91090, Lisses, France


REACH/22/3/0
REACH/22/3/1
REACH/22/3/2


Industrial use of 4-tert-OPnEO for its ‘wetting’ detergent properties in the production of buffers, reagents and gel supports allowing the dissolution, the dilution and the good spreading of substrates and reagents, necessary to optimize the functioning and the sensitivity of gel electrophoresis in vitro diagnostic test
Industrial use of 4-tert-OPnEO for its detergent properties in the production of electrophoresis gels in view of ensuring the positioning of specific proteins necessary for the interpretation of results of in vitro diagnostic test based on protein separation
Industrial use of 4-tert-OPnEO for its detergent properties resulting in cellular lysis and protein interactions rupture and required for the production of reagents involved in the determination of proteins of interest in gel and capillary electrophoresis in vitro diagnostic test


4 January 2033


In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the uses of the substance and there are no suitable alternative substances or technologies.






(1)  OJ L 396, 30.12.2006 , p. 1.

(2)  The decision is available on the European Commission website at: Authorisation (europa.eu).
Case T-661/20: Judgment of the General Court of 23 March 2022 — NV v eu-LISA (Civil service — Members of the temporary staff — Staff of eu-LISA — Disciplinary proceedings — Disciplinary penalty — Reprimand — Implementing provisions concerning administrative inquiries — Plea of illegality — Article 110 of the Staff Regulations — Failure to consult the Staff Committee — Rights of the defence and right to be heard — Articles 12, 12a, 17 and 19 of the Staff Regulations — Error of assessment — Principle of good administration — Article 10 of Annex IX to the Staff Regulations — Duty to have regard for the welfare of officials — Liability — Non-material damage)
Date: 2022-03-23
Institutions: General Court
Subjects: European official, administrative sanction, disciplinary proceedings, indemnification, rights of the defence, staff regulations (EU)








C_2022198EN.01003801.xml










16.5.2022   


EN


Official Journal of the European Union


C 198/38






Judgment of the General Court of 23 March 2022 — NV v eu-LISA
(Case T-661/20) (1)

(Civil service - Members of the temporary staff - Staff of eu-LISA - Disciplinary proceedings - Disciplinary penalty - Reprimand - Implementing provisions concerning administrative inquiries - Plea of illegality - Article 110 of the Staff Regulations - Failure to consult the Staff Committee - Rights of the defence and right to be heard - Articles 12, 12a, 17 and 19 of the Staff Regulations - Error of assessment - Principle of good administration - Article 10 of Annex IX to the Staff Regulations - Duty to have regard for the welfare of officials - Liability - Non-material damage)
(2022/C 198/53)
Language of the case: English

Parties


Applicant: NV (represented by: S. Rodrigues and A. Champetier, lawyers)

Defendant: European Union Agency for the Operational Management of Large-Scale IT Systems in the Area of Freedom, Security and Justice (eu-LISA) (represented by: M. Chiodi, acting as Agent, and by D. Waelbroeck and A. Duron, lawyers)

Re:

Application under Article 270 TFEU seeking, first, annulment of the decision of eu-LISA of 3 February 2020 to impose on the applicant the penalty of a reprimand and, secondly, compensation for the non-material harm allegedly suffered by the applicant as a result of that decision.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders NV to pay the costs.






(1)  OJ C 19, 18.1.2021.
Case T-129/19 RENV: Judgment of the General Court of 23 March 2022 — Necci v Commission (Civil service — Contract staff — Social security — JSIS — Rejection of the application for membership following a transfer of pension rights — Condition relating to a period of employment of more than three years — Article 95 of the CEOS — Article 34(1) of the Charter of Fundamental Rights — Article 45 TFEU)
Date: 2022-03-23
Institutions: General Court
Subjects: health insurance, servant (EU), staff regulations (EU), transfer of pension rights








C_2022207EN.01003302.xml










23.5.2022   


EN


Official Journal of the European Union


C 207/33






Judgment of the General Court of 23 March 2022 — Necci v Commission
(Case T-129/19 RENV) (1)

(Civil service - Contract staff - Social security - JSIS - Rejection of the application for membership following a transfer of pension rights - Condition relating to a period of employment of more than three years - Article 95 of the CEOS - Article 34(1) of the Charter of Fundamental Rights - Article 45 TFEU)
(2022/C 207/43)
Language of the case: French

Parties


Applicant: Claudio Necci (Brussels, Belgium) (represented by: S. Orlandi, lawyer)

Defendant: European Commission (represented by: B. Mongin and T. Bohr, acting as Agents)

Interveners in support of the defendant: European Parliament (represented by: J. Van Pottelberge and I. Terwinghe, acting as Agents), Council of the European Union (represented by: M. Bauer and M. Alver, acting as Agents)

Re:

By his action under Article 270 TFEU, the applicant seeks annulment of the decision of the European Commission of 18 April 2018 by which it impliedly rejected his application for membership of the Joint Sickness Insurance Scheme of the Institutions of the European Communities (JSIS) submitted on 18 December 2017.

Operative part of the judgment

The Court:






1.


Dismisses the action;










2.


Orders the European Commission to bear its own costs and those incurred by Mr Claudio Necci relating to the appeal proceedings before the Court of Justice, in Case C-202/20 P;










3.


Orders Mr Necci to pay the costs relating to the appeal proceedings before the General Court, in Case T-129/19 RENV, and relating to the initial proceedings before the General Court, in Case T-129/19;










4.


Orders the European Parliament and the Council of the European Union to bear their own costs relating to Case T-129/19 and to the present proceedings on referral.






(1)  OJ C 155, 6.5.2019.
Case T-342/21: Order of the General Court of 23 March 2022 — Bambu Sales v EUIPO (BAMBU) (EU trade mark — Revocation of the contested decision — Action which has become devoid of purpose — No need to adjudicate)
Date: 2022-03-23
Institutions: General Court
Subjects: EU trade mark, registered trade mark, smoking, trade-mark law








C_2022222EN.01002902.xml










7.6.2022   


EN


Official Journal of the European Union


C 222/29






Order of the General Court of 23 March 2022 — Bambu Sales v EUIPO (BAMBU)
(Case T-342/21) (1)

(EU trade mark - Revocation of the contested decision - Action which has become devoid of purpose - No need to adjudicate)
(2022/C 222/49)
Language of the case: English

Parties


Applicant: Bambu Sales, Inc. (Secaucus, New Jersey, United States) (represented by: T. Stein, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Hanf, acting as Agent)

Re:

Action brought against the decision of the First Board of Appeal of EUIPO of 20 April 2021 (Case R 1702/2020 1), concerning an application for registration of the word sign BAMBU as an EU trade mark.

Operative part of the order







1.


There is no longer any need to adjudicate on the action.










2.


The European Union Intellectual Property Office (EUIPO) shall bear its own costs and pay those incurred by Bambu Sales, Inc.






(1)  OJ C 329, 16.8.2021.